An independent report has been released today by Stevenage Bioscience Catalyst (SBC) that demonstrates its key role in delivering economic benefit from life sciences research and innovation in the UK.
The award win recognizes Nanoform as a listed company that places innovation at the center of its strategy for business development and introduces an innovative technology to the market.
While batch process chemistry remains the standard in the pharmaceutical industry, a clear increase in continuous flow processes has emerged over the past decade thanks to the commercialization of preparative flow reactor units. I
Life Science Integrates (LSI) is delighted with the success of its 10th Pharma Integrates conference, which took place on 16th November.
15 start-ups with huge potential have successfully completed the Data-driven Advanced Therapeutics Accelerator (DATA) programme at Stevenage Bioscience Catalyst (SBC), one of Europe’s most important science parks for life sciences.
Nanoform, an innovative nanoparticle medicine enabling company, today announced it has received ISO/IEC 27001:2013 certification for its Information Security Management System (ISMS).